search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


SCREAM


- candidate number21905
- NTR NumberNTR5165
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR2-apr-2015
- Secondary IDs113101001; 13-N-123 ZonMW; METC Atrium-Orbis
- Public TitleSCREAM
- Scientific TitleSupporting Clinical Rules Engine in the Adjustment of Medication
- ACRONYMSCREAM
- hypothesisThe primary objective of this study is to reduce the number of patients with at least one event when using the CRR (a computerised clinical descion support system) compared to the regular care. These events consist of hospital referrals, delirium, falls, and/or deaths
- Healt Condition(s) or Problem(s) studiedPolypharmacy, Medication review, Decision Support System (Clinical)
- Inclusion criteriaResidents living in a nursing home in the Netherlands. The nursing homes are able to deliver the medication and lab data electronically
- Exclusion criteriaWhen the inclusion criteria can't be met
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingSingle
- controlNot applicable
- group[default]
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-jun-2013
- planned closingdate1-jun-2016
- Target number of participants4000
- InterventionsA clinical decision support system, the CRR (clinical rule reporter) will be used to weekly screen medication list, laboratory values and medical history in order to obtain potential clinical relevant remarks that will be sent to the correspondant physician with an advice on how to improve/solve the situation.
- Primary outcomeThe primary outcome variable in this study is the proportion of patients with at least one of the events, including hospital referrals (i.e. referral to a specialist, emergency department visit and hospital admission), delirium, falls, and/or deaths. To this end the study will assess the differences between regular care (control group) and regular care + CRR (intervention group).
- Secondary outcomeAs secondary endpoints, the same outcome variable will be used to analyse the possible differences between institutions, to separately analyse psychogeriatric and somatic wards, to analyse the medication related events, and to separately analyse each of the parameters included in the combined endpoint (hospital referrals, delirium, falls, and/or deaths). Also the quality of life, the MAI and a cost evaluation will be performed for both control and intervention group.
- TimepointsApplying intervention for some centers and including more participants
- Trial web site
- status[default]
- CONTACT FOR PUBLIC QUERIESDr. PHM van der Kuy
- CONTACT for SCIENTIFIC QUERIESDr. PHM van der Kuy
- Sponsor/Initiator Atrium-Orbis Medisch Centrum
- Funding
(Source(s) of Monetary or Material Support)
ZON-MW, The Netherlands Organization for Health Research and Development
- Publications
- Brief summary
- Main changes (audit trail)
- RECORD2-apr-2015 - 8-jun-2015


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl